Comparison

Oclacitinib maleate

Manufacturer Molnova
Category
Type Inhibitors
Specific against other
Amount 5 mg
Item no. MOLN-M17356-5mg
Targets Aurora Kinase
CASRN 1640292-55-2
eClass 6.1 30220300
eClass 9.0 32160605
Available
Brief description
Oclacitinib is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases.
Molecular Weight
453, 51
Note
Research use only, not for human use.
Stability
≥ 2 years
Storage
(-20℃)
Receptor
Aurora Kinase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Delivery expected until 6/6/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close